ENDOVAC-EQUI

LIVE

Serial Number

88092302

Owner

ENDOVAC ANIMAL HEALTH LLC

Attorney

Cathy J. Futrowsky

First Use Date

Jun 7, 1988

Filing Date

Aug 24, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ENDOVAC-EQUI Trademark

Serial Number: 88092302 • Registration: 5803745

ENDOVAC-EQUI is a trademark filed by ENDOVAC ANIMAL HEALTH LLC on August 24, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

ENDOVAC ANIMAL HEALTH LLC (28 trademarks)

Columbia, MO 65201

Entity Type: 03

Legal Representation

Attorney of Record

Cathy J. Futrowsky

295 trademarks filed View all →

Correspondence Address

Cathy J. Futrowsky EVANS & DIXON, L.L.C.

211 N. Broadway, Suite 2500

Metropolitan Square

ST. LOUIS, MO 63102

United States

Trademark Details

Filing Date

August 24, 2018

Registration Date

July 16, 2019

First Use Anywhere

June 7, 1988

Published for Opposition

April 30, 2019

Goods & Services

Veterinary preparations, namely, antiserums for veterinary use for the treatment of gram negative endotoxemia in livestock, namely, equine

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Aug 7, 2025 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Aug 7, 2025 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Aug 6, 2025 APRE

TEAS SECTION 8 & 15 RECEIVED

Apr 2, 2025 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 16, 2024 REM1

REGISTERED-PRINCIPAL REGISTER

Jul 16, 2019 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 30, 2019 NPUB

PUBLISHED FOR OPPOSITION

Apr 30, 2019 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 10, 2019 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 20, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 27, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 27, 2019 CRFA

ASSIGNED TO LIE

Feb 27, 2019 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 22, 2019 TROA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Dec 12, 2018 GPRN

PRIORITY ACTION E-MAILED

Dec 12, 2018 GPRA

PRIORITY ACTION WRITTEN

Dec 12, 2018 CPRA

ASSIGNED TO EXAMINER

Dec 10, 2018 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 5, 2018 NWOS

NEW APPLICATION ENTERED

Aug 28, 2018 NWAP

Related Trademarks

More from this Owner

ENDOVAC

ENDOVAC-EQUI WITH IMMUNE PLUS

ENDOVAC-DAIRY WITH IMMUNE PLUS

More in Same Class

PREMIERZEN

AVERITAS PHARMA

VERRICA PHARMACEUTICALS

MOLECULAC

GREEN COMPLEX

K9 ATHLETE